✦ LIBER ✦

High-dose BEAM in lymphoma: advantages over other regimens

Book ID: 120856068
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2004
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200414680-00039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BEAM antineoplastic regimen effective in

BEAM antineoplastic regimen effective in high-risk lymphoma

📂 Article 📅 1997 🏛 Adis International Limited (now part of Wolters Kl ⚖ 185 KB

High-dose chemotherapy in tumours other

High-dose chemotherapy in tumours other than lymphomas and breast cancer

✍ J.P. Droz; P. Biron 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 271 KB

Busulfan, cyclophosphamide, and etoposid

Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma

✍ M. Hänel; N. Kröger; S. Sonnenberg; M. Bornhäuser; W. Krüger; F. Kroschinsky; A. 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 73 KB

High-dose CEB vs BEAM with autologous st

High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma

✍ Wang, E H; Chen, Y A; Corringham, S; Bashey, A; Holman, P; Ball, E D; Carrier, E 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

High-dose CEB versus beam with autologou

High-dose CEB versus beam with autologous stem cell transplant in lymphoma

✍ E. Carrier; E.H. Wang; Y. Chen; J. Castro; E.T. Ball; A. Bashey; P. Holman; S. C 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Sirolimus in liver transplant recipients

Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens

✍ Derek DuBay; Rob J. Smith; Kenneth G. Qiu; Gary A. Levy; Leslie Lilly; George Th 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

The purpose of this study is to review the clinical experience with sirolimus immunosuppression in liver transplant patients with calcineurin inhibitor-induced chronic renal insufficiency. The study design is a case-control retrospective series. Fifty-seven liver transplant patients with renal insuf